Xias Bio

Developer of recombinant proteins

placeGlasgow, Glasgow City, United States calendar_todayFounded 2020 language xiasbio.com

Registered entities

Innovation

3 patent families — focus: Chemistry & metallurgy; filing pace accelerating. Cited 9 times.

YearFilings
20231
20252

Social engagement

Social engagement: 893 social following, 8 posts in the last 12 months — top quartile of its industry.

Investor mix

2 investors on record; lead investors include IndieBio.

Investor typeCountShare
Venture capital150%
Accelerator & incubator150%

Recent activity

23 Jun 2026
Event
SCS Annual Conference
3 Jun 2026
Event
SCS Annual Conference
6 Jan 2026
Event
Cosmet'Agora
Coming soon